Stock Analysis on Net
Stock Analysis on Net

Abiomed Inc. (NASDAQ:ABMD)

この会社は アーカイブに移動しました! 2022年11月3日以降、財務データは更新されていません。

デュポンの分析: ROE、ROA、純利益率の内訳 
四半期データ

Microsoft Excel

ROE分解では、純利益を株主資本で割ったものを構成比率の積として表します。

ROEを2つのコンポーネントに分解

Abiomed Inc.、 ROE の分解(四半期データ)

Microsoft Excel
ROE = ROA × 財務レバレッジ比率
2022/09/30 17.32% = 15.72% × 1.10
2022/06/30 14.16% = 12.77% × 1.11
2022/03/31 9.08% = 8.16% × 1.11
2021/12/31 9.28% = 8.35% × 1.11
2021/09/30 10.77% = 9.75% × 1.11
2021/06/30 11.81% = 10.59% × 1.12
2021/03/31 16.96% = 15.09% × 1.12
2020/12/31 15.89% = 14.03% × 1.13
2020/09/30 17.58% = 15.65% × 1.12
2020/06/30 14.40% = 12.70% × 1.13
2020/03/31 19.05% = 16.69% × 1.14
2019/12/31 23.42% = 20.49% × 1.14
2019/09/30 22.27% = 19.64% × 1.13
2019/06/30 25.72% = 22.92% × 1.12
2019/03/31 27.65% = 24.57% × 1.13
2018/12/31 26.06% = 23.18% × 1.12
2018/09/30 24.02% = 21.47% × 1.12
2018/06/30 22.79% = 20.30% × 1.12
2018/03/31 16.27% = 14.26% × 1.14
2017/12/31 14.26% = 12.54% × 1.14
2017/09/30 15.24% = 13.27% × 1.15
2017/06/30 13.51% = 11.74% × 1.15
2017/03/31 11.53% = 9.47% × 1.22
2016/12/31 — = — × 1.20
2016/09/30 — = — × 1.19
2016/06/30 — = — × 1.14

レポートに基づく: 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-K (報告日: 2022-03-31), 10-Q (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-K (報告日: 2021-03-31), 10-Q (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-K (報告日: 2020-03-31), 10-Q (報告日: 2019-12-31), 10-Q (報告日: 2019-09-30), 10-Q (報告日: 2019-06-30), 10-K (報告日: 2019-03-31), 10-Q (報告日: 2018-12-31), 10-Q (報告日: 2018-09-30), 10-Q (報告日: 2018-06-30), 10-K (報告日: 2018-03-31), 10-Q (報告日: 2017-12-31), 10-Q (報告日: 2017-09-30), 10-Q (報告日: 2017-06-30), 10-K (報告日: 2017-03-31), 10-Q (報告日: 2016-12-31), 10-Q (報告日: 2016-09-30), 10-Q (報告日: 2016-06-30).

2023年第2 四半期に株主資本利益率(ROE)が増加した主な理由は、総資産利益率(ROA)で測定される収益性の増加です。

ROEを3つの要素に分解

Abiomed Inc.、 ROE の分解(四半期データ)

Microsoft Excel
ROE = 純利益率 × 資産回転率 × 財務レバレッジ比率
2022/09/30 17.32% = 24.84% × 0.63 × 1.10
2022/06/30 14.16% = 20.60% × 0.62 × 1.11
2022/03/31 9.08% = 13.23% × 0.62 × 1.11
2021/12/31 9.28% = 13.26% × 0.63 × 1.11
2021/09/30 10.77% = 15.32% × 0.64 × 1.11
2021/06/30 11.81% = 16.51% × 0.64 × 1.12
2021/03/31 16.96% = 26.61% × 0.57 × 1.12
2020/12/31 15.89% = 24.66% × 0.57 × 1.13
2020/09/30 17.58% = 25.88% × 0.60 × 1.12
2020/06/30 14.40% = 19.88% × 0.64 × 1.13
2020/03/31 19.05% = 24.14% × 0.69 × 1.14
2019/12/31 23.42% = 29.14% × 0.70 × 1.14
2019/09/30 22.27% = 26.92% × 0.73 × 1.13
2019/06/30 25.72% = 32.35% × 0.71 × 1.12
2019/03/31 27.65% = 33.66% × 0.73 × 1.13
2018/12/31 26.06% = 30.12% × 0.77 × 1.12
2018/09/30 24.02% = 27.60% × 0.78 × 1.12
2018/06/30 22.79% = 25.71% × 0.79 × 1.12
2018/03/31 16.27% = 18.89% × 0.76 × 1.14
2017/12/31 14.26% = 16.59% × 0.76 × 1.14
2017/09/30 15.24% = 18.27% × 0.73 × 1.15
2017/06/30 13.51% = 16.13% × 0.73 × 1.15
2017/03/31 11.53% = 11.70% × 0.81 × 1.22
2016/12/31 — = — × — × 1.20
2016/09/30 — = — × — × 1.19
2016/06/30 — = — × — × 1.14

レポートに基づく: 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-K (報告日: 2022-03-31), 10-Q (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-K (報告日: 2021-03-31), 10-Q (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-K (報告日: 2020-03-31), 10-Q (報告日: 2019-12-31), 10-Q (報告日: 2019-09-30), 10-Q (報告日: 2019-06-30), 10-K (報告日: 2019-03-31), 10-Q (報告日: 2018-12-31), 10-Q (報告日: 2018-09-30), 10-Q (報告日: 2018-06-30), 10-K (報告日: 2018-03-31), 10-Q (報告日: 2017-12-31), 10-Q (報告日: 2017-09-30), 10-Q (報告日: 2017-06-30), 10-K (報告日: 2017-03-31), 10-Q (報告日: 2016-12-31), 10-Q (報告日: 2016-09-30), 10-Q (報告日: 2016-06-30).

2023年第2 四半期に株主資本利益率(ROE)が増加した主な理由は、純利益率で測定した収益性の増加です。

ROAを2つのコンポーネントに分解

Abiomed Inc.、 ROA の分解(四半期データ)

Microsoft Excel
ROA = 純利益率 × 資産回転率
2022/09/30 15.72% = 24.84% × 0.63
2022/06/30 12.77% = 20.60% × 0.62
2022/03/31 8.16% = 13.23% × 0.62
2021/12/31 8.35% = 13.26% × 0.63
2021/09/30 9.75% = 15.32% × 0.64
2021/06/30 10.59% = 16.51% × 0.64
2021/03/31 15.09% = 26.61% × 0.57
2020/12/31 14.03% = 24.66% × 0.57
2020/09/30 15.65% = 25.88% × 0.60
2020/06/30 12.70% = 19.88% × 0.64
2020/03/31 16.69% = 24.14% × 0.69
2019/12/31 20.49% = 29.14% × 0.70
2019/09/30 19.64% = 26.92% × 0.73
2019/06/30 22.92% = 32.35% × 0.71
2019/03/31 24.57% = 33.66% × 0.73
2018/12/31 23.18% = 30.12% × 0.77
2018/09/30 21.47% = 27.60% × 0.78
2018/06/30 20.30% = 25.71% × 0.79
2018/03/31 14.26% = 18.89% × 0.76
2017/12/31 12.54% = 16.59% × 0.76
2017/09/30 13.27% = 18.27% × 0.73
2017/06/30 11.74% = 16.13% × 0.73
2017/03/31 9.47% = 11.70% × 0.81
2016/12/31 — = — × —
2016/09/30 — = — × —
2016/06/30 — = — × —

レポートに基づく: 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-K (報告日: 2022-03-31), 10-Q (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-K (報告日: 2021-03-31), 10-Q (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-K (報告日: 2020-03-31), 10-Q (報告日: 2019-12-31), 10-Q (報告日: 2019-09-30), 10-Q (報告日: 2019-06-30), 10-K (報告日: 2019-03-31), 10-Q (報告日: 2018-12-31), 10-Q (報告日: 2018-09-30), 10-Q (報告日: 2018-06-30), 10-K (報告日: 2018-03-31), 10-Q (報告日: 2017-12-31), 10-Q (報告日: 2017-09-30), 10-Q (報告日: 2017-06-30), 10-K (報告日: 2017-03-31), 10-Q (報告日: 2016-12-31), 10-Q (報告日: 2016-09-30), 10-Q (報告日: 2016-06-30).

2023年第2 四半期に総資産利益率(ROA)が増加した主な理由は、純利益率で測定した収益性の増加です。